• Profile
Close

Efficacy of topical combination of 0.25% finasteride and 3% minoxidil vs 3% minoxidil solution in female pattern hair loss: A randomized, double-blind, controlled study

American Journal of Clinical Dermatology Feb 20, 2019

Suchonwanit P, et al. - In this prospective, randomized, double-blind study, 30 postmenopausal females were studied to analyze the effectiveness and safety of topical 0.25% finasteride plus 3% minoxidil solution and 3% minoxidil solution alone in the treatment of female pattern hair loss (FPHL). Overall, researchers found no systemic side effects, but did note an increase in hair density and diameter in both groups by 24 weeks. Combination finasteride/minoxidil, however, was found to be significantly superior to the minoxidil only with respect to hair diameter. Though, serum dihydrotestosterone levels in the finasteride/minoxidil group significantly decreased from baseline.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay